Cargando…

Overcoming CEP85L-ROS1, MKRN1-BRAF and MET amplification as rare, acquired resistance mutations to Osimertinib

Lung cancer is the most common cancer-related cause of death worldwide, most of which are non-small cell lung cancers (NSCLC). Epidermal growth factor receptor (EGFR) mutations are common drivers of NSCLC. Treatment plans for NSCLC, specifically adenocarcinomas, rely heavily on the presence or absen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kian, Waleed, Krayim, Bilal, Alsana, Hadel, Giles, Betsy, Purim, Ofer, Alguayn, Wafeek, Alguayn, Farouq, Peled, Nir, Roisman, Laila C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009227/ https://www.ncbi.nlm.nih.gov/pubmed/36923435 http://dx.doi.org/10.3389/fonc.2023.1124949

Ejemplares similares

Hypercalcemia as a Rebound Phenomenon of LOXO-292 Efficacy in Medullary Thyroid Cancer
por: Kian, Waleed, et al.
Publicado: (2020)

Epithelioid Hemangioendothelioma and Epithelioid Hemangioma: Pazopanib as a Potential Salvage Therapy
por: Yakobson, Alexander, et al.
Publicado: (2021)

Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options: A retrospective single-center study
por: Kian, Waleed, et al.
Publicado: (2022)

Dose escalation of osimertinib for intracranial progression in EGFR mutated non-small-cell lung cancer with brain metastases
por: Goldstein, Iris M, et al.
Publicado: (2020)

Intravenous immunoglobulin efficacy on pembrolizumab induced severe toxic epidermal necrolysis
por: Kian, Waleed, et al.
Publicado: (2021)

Osimertinib in advanced EGFR-mutant lung adenocarcinoma with asymptomatic brain metastases: an open-label, 3-arm, phase II pilot study
por: Peled, Nir, et al.
Publicado: (2021)

Improved first-pass effect in acute stroke thrombectomy using Solitaire-X compared to Solitaire-FR
por: Biederko, Ron, et al.
Publicado: (2023)

Real-world efficacy and safety of mobocertinib in EGFR exon 20 insertion-mutated lung cancer
por: Kian, Waleed, et al.
Publicado: (2022)

Programmed death-ligand 1 expression discrepancy between primary tumor and metastatic lymph nodes in non-small cell lung cancer
por: Kian, Waleed, et al.
Publicado: (2020)

1589P Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options
por: Zemel, M., et al.
Publicado: (2021)

Radiological artificial intelligence - predicting personalized immunotherapy outcomes in lung cancer
por: Roisman, Laila C., et al.
Publicado: (2023)

Characterization of Cep85 – a new antagonist of Nek2A that is involved in the regulation of centrosome disjunction
por: Chen, Canhe, et al.
Publicado: (2015)

Direct binding of CEP85 to STIL ensures robust PLK4 activation and efficient centriole assembly
por: Liu, Yi, et al.
Publicado: (2018)

Lung Cancer in Young Patients: Higher Rate of Driver Mutations and Brain Involvement, but Better Survival
por: Suidan, Anna May, et al.
Publicado: (2019)

Visualization of both proximal M2-MCA segments in patients (the Tilted-V Sign) with acute M1-MCA occlusion stroke is associated with better procedural and prognostic outcomes
por: Azriel, Amit, et al.
Publicado: (2022)

MKRN1: Uncovering function by an unbiased systems approach
por: Carpenedo, Richard L., et al.
Publicado: (2015)

Methylation status of hypothalamic Mkrn3 promoter across puberty
por: Fanis, Pavlos, et al.
Publicado: (2023)

Combined targeting of EGFR and BRAF triggers regression of osimertinib resistance by using osimertinib and vemurafenib concurrently in a patient with heterogeneity between different lesions
por: Sun, Mengyao, et al.
Publicado: (2021)

Cep85 Relays Plk1 Activity to Phosphorylated Nek2A for Its Timely Activation in Centrosome Disjunction
por: Chen, Canhe, et al.
Publicado: (2018)

COVID-19 Vaccination Among the Arab Bedouin Population: Lessons Learned From a Minority Population
por: Abu-Freha, Naim, et al.
Publicado: (2022)

Investigation of MKRN3 Mutation in Patients with Familial Central Precocious Puberty
por: Aycan, Zehra, et al.
Publicado: (2018)

MKRN3 and KISS1R mutations in precocious and early puberty
por: Pagani, Sara, et al.
Publicado: (2020)

The role of kisspeptin and MKRN3 in the diagnosis of central precocious puberty in girls
por: Li, Mei, et al.
Publicado: (2021)

MKRN2 inhibits the proliferation of gastric cancer by downregulating PKM2
por: Liu, Zheng, et al.
Publicado: (2022)

Cep70 and Cep131 contribute to ciliogenesis in zebrafish embryos
por: Wilkinson, Christopher J, et al.
Publicado: (2009)

Cep63 and Cep152 Cooperate to Ensure Centriole Duplication
por: Brown, Nicola J., et al.
Publicado: (2013)

Liquid First Is “Solid” in Naïve Non-Small Cell Lung Cancer Patients: Faster Turnaround Time With High Concordance to Solid Next-Generation Sequencing
por: Sehayek, Or, et al.
Publicado: (2022)

Deficiency of Mkrn2 causes abnormal spermiogenesis and spermiation, and impairs male fertility
por: Qian, Xu, et al.
Publicado: (2016)

Association between MKRN3 and LIN28B polymorphisms and precocious puberty
por: Yi, Bo Ram, et al.
Publicado: (2018)

Conservation of Imprinting and Methylation of MKRN3, MAGEL2 and NDN Genes in Cattle
por: Li, Junliang, et al.
Publicado: (2021)

MKRN3 role in regulating pubertal onset: the state of art of functional studies
por: Palumbo, Stefania, et al.
Publicado: (2022)

Six Novel Variants in the MKRN3 Gene Causing Central Precocious Puberty
por: Gernay, Caroline, et al.
Publicado: (2022)

Acquired BRAF gene fusions in Osimertinib resistant EGFR-mutant non-small cell lung cancer
por: Rosell, Rafael, et al.
Publicado: (2023)

Pharmacokinetic Evaluation of [(11)C]CEP-32496 in Nude Mice Bearing BRAF(V600E) Mutation-Induced Melanomas
por: Jiang, Cuiping, et al.
Publicado: (2018)

(Epi)genetic defects of MKRN3 are rare in Asian patients with central precocious puberty
por: Suzuki, Erina, et al.
Publicado: (2019)

The first Japanese case of central precocious puberty with a novel MKRN3 mutation
por: Nishioka, Junko, et al.
Publicado: (2017)

MKRN3 Mutations in Central Precocious Puberty: A Systematic Review and Meta-Analysis
por: Valadares, Luciana Pinto, et al.
Publicado: (2019)

MKRN3 regulates the epigenetic switch of mammalian puberty via ubiquitination of MBD3
por: Li, Chuanyin, et al.
Publicado: (2020)

NKp44-Derived Peptide Used in Combination Stimulates Antineoplastic Efficacy of Targeted Therapeutic Drugs
por: Iraqi, Muhammed, et al.
Publicado: (2022)

CEP19 cooperates with FOP and CEP350 to drive early steps in the ciliogenesis programme
por: Mojarad, Bahareh A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ot4dgcskbn1duk0prp3q19ug3m